XSPRAY — Xspray Pharma publ AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Xspray Pharma publ AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	272	120	166	208	154
Net Total Accounts Receivable
Net Total Receivables	2.5	2.58	4.17	4.02	3.84
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	282	132	218	235	183
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	44.6	64.6	108	79.2	71
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	623	585	765	796	769
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30	28.9	39.9	146	21.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	31.2	29.4	71.8	173	165
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	592	556	693	623	605
Total Liabilities & Shareholders' Equity	623	585	765	796	769
Total Common Shares Outstanding